My WordPress Blog
Developing the right regulatory strategy is one of the most critical steps in successfully bringing a medical device to the U.S. market. The U.S. Food and Drug Administration (FDA) requires medical devices to follow specific premarket pathways, and choosing the correct route can save time, reduce costs, and improve approval [...]
Veterinary medical devices are regulated similarly to human medical devices, with the FDA providing guidance to ensure safety, efficacy, and regulatory compliance for animal health products. Manufacturers, importers, and distributors must comply with device registration, product listing, labeling, and safety reporting requirements to legally market veterinary devices in the United [...]
The FDA regulates color additives and food contact substances (FCS) to ensure safety for consumers. Companies introducing new color additives or materials intended for contact with food must comply with rigorous FDA requirements, including premarket approval, notifications, and safety testing. At XPRO AMERICA, we provide end-to-end guidance for manufacturers, distributors, [...]
Premarket Approval (PMA) is the FDA’s regulatory pathway for high-risk Class III medical devices, which require extensive scientific evidence demonstrating safety and effectiveness before marketing in the United States. Unlike 510(k) or De Novo submissions, PMA applications often involve clinical study data and rigorous review processes. At XPRO AMERICA, we [...]
The De Novo classification pathway is designed for novel, low- to moderate-risk medical devices that do not have a predicate device for 510(k) submission. This pathway allows manufacturers to obtain FDA marketing authorization by demonstrating safety and effectiveness while establishing a new device classification. At XPRO AMERICA, we provide expert [...]